Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mianserin vs Lorazepam with Escitalopram for Depression with Sleep Problems
NCT05599126Phase 4Recruiting
- Start
- Jul 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mianserin in major depressive disorder (MDD) and Insomnia (2 arms). Primary endpoint: Pittsburgh Sleep Quality Index at 8 weeks. Started Jul 2024; status: recruiting.
02
Drugs
mianserin
03
Conditions
major depressive disorder (MDD)Insomnia
Beyond the preview
Go deeper on NCT05599126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05599126.